The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer
NCT01777230 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2014-12-18
Summary
Objective of the study: To study the concordance of sentinel node (SN) localization between preoperative Magnetic Resonance Lymphangiography and SPECT-CT SN mapping and the intra-operative SN procedure for low stage cervical cancer.
Background: The SN procedure for surgically treated cervical cancer is promising. Unfortunately, efficient and direct intra-operative SN localisation, without an extensive surgical exploration, remains a challenge even with combined use of patent blue dye en technetium-99m (99mTc). Preoperative imaging (= mapping) with 99mTc based SPECT-CT, which is increasingly adopted, has partly alleviated this problem. The investigators aim to investigate the feasibility of a new SN mapping modality, which visualises the (sentinel) lymph nodes using a Magnetic Resonance Imaging (MRI) technique (so called; Magnetic Resonance Lymphangiography), and compare it to SPECT-CT.
Design: Prospective, feasibility type diagnostic study. 40 subjects targeted. Via vaginal speculum exam, a specific MRI contrast-agent will be intracervically injected. Subsequently, on a wide bore 1.5T MRI system multiplanar imaging is performed, followed by a blinded review (experienced radiologist) for bilateral SN localization. Standard care with a preoperative SPECT-CT (after intracervical 99mTc administration). A blinded nuclear medicine specialist will localize the SN on the SPECT-CT images. Open or (robot-assisted) laparoscopy performed for localization of the blue stained and/or 99mTc-hot SN. Excision of the SN with freeze sectioning and histological review. Statistical analysis with intrapatient testing for concordance of MR Lympangiography and SPECT-CT based SN localization against the reference standard: the intra-operative sentinel node procedure.
Conditions
Interventions
- PROCEDURE
-
SPECT-CT sentinel node mapping
sentinel node localisation using the nuclear medicine technique SPECT-CT
- PROCEDURE
-
Magnetic Resonance Lymphangiography sentinel node mapping
Sentinel node localisation using Magnetic Resonance Lymphangiography
- PROCEDURE
-
Intra-operative sentinel node procedure
Open or (robot-assisted) laparoscopic sentinel node detection and resection.
Sponsors & Collaborators
-
UMC Utrecht
lead OTHER
Principal Investigators
-
Ronald Zweemer, MD PhD · UMC Utrecht
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients
NCT05145829 ·Status: UNKNOWN ·Phase: NA
-
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
NCT06083103 ·Status: RECRUITING
-
Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy
NCT01663753 ·Status: COMPLETED ·Phase: NA
-
Prediction of Clinical Response and Outcome in Uterine Cervix Cancer
NCT01764217 ·Status: COMPLETED
-
FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
NCT02317302 ·Status: TERMINATED ·Phase: PHASE1
-
PET CT With HX4 in Cervix Cancer
NCT02233387 ·Status: TERMINATED ·Phase: PHASE2
-
The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma
NCT03877627 ·Status: UNKNOWN ·Phase: NA
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
NCT05068687 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Mapping In Endometrial Cancer
NCT03778255 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients
NCT05054062 ·Status: COMPLETED ·Phase: NA
-
Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix
NCT00193752 ·Status: COMPLETED
-
The Diagnostic Value of PET/MRI in Head and Neck Cancer
NCT04117139 ·Status: UNKNOWN ·Phase: NA
-
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
NCT03817307 ·Status: UNKNOWN ·Phase: NA
-
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
NCT02180308 ·Status: COMPLETED
-
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
NCT00416455 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
NCT02469922 ·Status: COMPLETED ·Phase: NA
-
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
NCT00775957 ·Status: TERMINATED
-
SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification
NCT04803331 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer
NCT02243059 ·Status: WITHDRAWN ·Phase: PHASE4
-
Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer
NCT05446324 ·Status: RECRUITING ·Phase: PHASE3
-
MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer
NCT06273501 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
NCT00313027 ·Status: COMPLETED ·Phase: NA
-
FLT PET Imaging for Cervical Cancer
NCT01075412 ·Status: TERMINATED ·Phase: PHASE2
-
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
NCT06835426 ·Status: RECRUITING ·Phase: NA